CorrlensCorrlens
Correlate

Correlation Analysis

Apollo Global Management, Inc. vs Johnson & Johnson

APO vs JNJ

+0.011

Near-zero positive

When one moves up, the other tends to follow.

APO logo

Apollo Global Management, Inc.

APO

Apollo is one of the world's largest alternative asset managers, with $938.4 billion in total assets under management, or AUM, including $709.1 billion in fee-earning assets, at the end of 2025. The company has two core operating segments: asset management and retirement services. Apollo operates with scale in each of its major product lines—private equity (with $128.4 billion in total AUM and $75.0 billion in fee-earning AUM), real estate/real assets ($60.8 billion/$27.6 billion), and credit ($749.2 billion/$606.5 billion). Apollo has a distribution profile that is likely not too far off from the industry averages—with 84% of its assets held by institutional investors and 16% by high-net-worth clients.

Market cap 61.4B · 4,130 employees

JNJ logo

Johnson & Johnson

JNJ

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Market cap 580.4B

Apr 9, 2021 — Apr 7, 2026Daily1,254 data pointsStockStockHealthcare

Time Series

Relative Performance

Green: APOGray: JNJ36 of 1,254 points (sampled)

Who Moves First

APO leads JNJ by 6 days

APO tends to move before JNJ.

After testing 13 timing shifts, the strongest relationship was +0.029 (they moved in the same direction).

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.535

9 periods · Return correlation when both series rose

Both Falling

-0.186

6 periods · Return correlation when both series fell

Diverging

-0.722

20 periods · Return correlation when series moved apart

R-Squared

0.0%

Share of variance in one series explained by the other.

Trend Agreement

50.1%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

n.s.

95% CI: [-0.045, 0.066]

Scatter

XY Regression

37.2406080100120140160179.4135.5140160180200220240252.6Apollo Global Management, Inc.Johnson & JohnsonData pointsFit (r = 0.011)

Pipeline

Data quality details

Pipeline Summary

1,254 paired data points survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

APO logo

Apollo Global Management, Inc.

APO

Market cap 61.4B · 4,130 employees

Stock · 1,254 raw → 1,254 prepared

Series B

JNJ logo

Johnson & Johnson

JNJ

Market cap 580.4B

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

6

Estimated crossover points between normalized spreads.

Slope

0.0059

Linear regression slope.

Intercept

167.9350

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 4 hours ago · ID: stock-apo-vs-stock-jnj-daily